Clinical Trial

Gamma-Music Based Intervention for Mild Alzheimer's Disease

Study acronym: NUGammaMBI
Recruiting
View on ClinicalTrials.gov →
Summary
The study will test and refine a novel brain-stimulation tool using gamma-frequency lights coupled with self-selected music for a gamma-music-based intervention for participants with mild Alzheimer's Disease. Results will yield a gamma-stimulation protocol that reliably influences brain activity (Aim 1), is adaptive, motivating and rewarding to use (Aim 2), and will generate predictions as to who might benefit the most from gamma-MBI (Aim 3). By bridging the gap between neurostimulation and behavioral intervention by combining music therapy with gamma- band neurostimulation, the present project aims to find a sustainable intervention that delays the progression of AD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-01.
Trial Details
NCT Number NCT05984524
Lead Sponsor Northeastern University
Conditions Alzheimer Disease
Enrollment 60 participants
Start Date 2022-07-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-10-06